Table 4.

Phenotypic correction of C57BI/6 hemophilia-B mice treated with different amounts of the high-capacity AdFTC/hFIX or fgAdh/FIX

GroupTreatment: virus (transducing particles)Serum levels hFIX, ng/mLTail clip bleeding time, min
AdFTC/hFIX (1 × 10934 227 ± 14 457 3.1 ± 0.5 
AdFTC/hFIX (5 × 10812 143 ± 5 447 3.7 ± 0.3 
AdFTC/hFIX (1 × 1083 341 ± 1 227 3.8 ± 0.4 
FgAdhFIX (1 × 109910 ± 137 5.2 ± 0.2  
Vehicle (PBS) No clotting (> 30 min) 
GroupTreatment: virus (transducing particles)Serum levels hFIX, ng/mLTail clip bleeding time, min
AdFTC/hFIX (1 × 10934 227 ± 14 457 3.1 ± 0.5 
AdFTC/hFIX (5 × 10812 143 ± 5 447 3.7 ± 0.3 
AdFTC/hFIX (1 × 1083 341 ± 1 227 3.8 ± 0.4 
FgAdhFIX (1 × 109910 ± 137 5.2 ± 0.2  
Vehicle (PBS) No clotting (> 30 min) 

On day 3 after injection, an enzyme-linked immunosorbent assay for human factor IX expression levels was performed, and on day 6, a tail clip assay was performed. All groups are of hemophilic mice.

PBS indicates phosphate-buffered saline. For other abbreviations, see Table 2.

Close Modal

or Create an Account

Close Modal
Close Modal